You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Rapid electrochemical detection of arsenic in water

    SBC: LYNNTECH INC.            Topic: NIEHS

    PROJECT SUMMARYArsenic in drinking water poses a serious health hazard to tens of millions of peopleespecially in parts of the world where the arsenic concentrations far exceed theppb guideline value set by the World Health OrganizationAccording to a recent studyapproximatelyM people in the conterminous U Suse water from domestic wellsmillion out of themillion peopleare predicted to be using wells ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  2. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing

    SBC: Nuprobe Usa, Inc.            Topic: 102

    Summary Cell free DNAcfDNAin peripheral blood contain tumor derived DNA and are promising noninvasive biomarkers for cancer therapy selection and recurrence monitoringHoweverthe high cost of current commercial next generation sequencingNGSpanels for profiling cancer mutations in cfDNA prevents them from being routinely usedFurthermorethe high sequencing depth and reads required means that cfDNA pr ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  3. Hybrid ELISA: Simple and specific one-tier assay for Lyme disease

    SBC: KEPHERA DIAGNOSTICS LLC            Topic: NIAID

    Abstract Lyme disease, caused by infection with the spirochete Borrelia burgdorferi or closely related species, is the most common vector-borne disease in the United States, accounting for over 300,000 infections per year according to public health estimates. It is also one of the few infectious diseases that requires a two-step laboratory testing protocol, comprising a screening assay, typically ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. Rat Germline Gene Editing Products and Services

    SBC: GenomeDesigns Laboratory LLC            Topic: NIDA

    Summary Rat research models are established to investigate a broad spectrum of human health issues significant to most NIH Institutes and are reported in andgt;1.5 million publications listed on NCBI PubMed Central. Direct germline editing products and services generated by this SBIR project will streamline production of the most sophisticated, genetically designed rat models used to study gene, c ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy

    SBC: SAB Biotherapeutics, Inc.            Topic: NIAID

    Project Summary Abstract Currently available anti thymocyte globulinATGproducts are polyclonal animal antibodiesATGAMequine polyclonal ATGThymoglobulinrabbit polyclonal ATGand have found broad use as immune tolerizing agentsparticularly for induction therapy in a majority of tissue transplantsfor acute transplant rejectionand as treatment for graft vshost disease following bone marrow transplantsE ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  6. Marijuana Breath Analyzer

    SBC: GINER INC            Topic: NIDA

    PROJECT SUMMARY/ABSTRACT Marijuana Breath Analyzer The overall goal of this program is a THC breath analyzer that will provide rapid, accurate, and non-invasive determination of recent marijuana use at point-of-collection testing (POCT). Authorities will obtain breath samples noninvasively as they currently do in alcohol testing and receive the results on the spot. This field device for enforcemen ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  7. The DRUID App to Test Impairment

    SBC: DRUIDapp, Inc.            Topic: NIDA

    The DRUIDApp to Test ImpairmentAbstract The objective of this Fast Track proposal is to demonstrate proof of concept and efficacy of a portable cognitive behavioral assessment toolthe DRUIDappthat measures impairment from cannabisalcohol or other sourcesThis device will be available for use by military to assess mission readiness and training limitsfor workplaces and transportation systems to asse ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Novel accurate therapy for Multiple Sclerosis: Optimization of antisense oligonucleotides delivery and functionality in primary T cells

    SBC: Autoimmunity Biologic Solutions, Inc.            Topic: NIAID

    PROJECT SUMMARY Multiple SclerosisMSis the most common neurological disease of early adulthood and is mediated by autoimmune mechanisms that lead to demyelination and neuronal damage in the central nervous systemresulting in progressive neurological dysfunctionThere is no cure for the disease and current treatments focus on preventing future immunological attacksmainly by suppressing the immune sy ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Neonatal Opioid Screening Using Aptamers and Compensated Interferometry

    SBC: BASE PAIR BIOTECHNOLOGIES INC            Topic: NIDA

    Project Summary/Abstract The United States is experiencing an opioid epidemic of unprecedented scope. More than 6 out of 10 drug overdoses are now opioid-related, resulting in ~90 deaths/day. The economic impact of the epidemic has been estimated to exceed $75B/year, primarily from health and social costs related to prescription opioid use [Pain Med. 2011; 12(4):657-67. 2013; 14(10):1534-47]. New ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Lead Optimization of Peripheral CB1 Neutral Antagonists for Renal Diseases

    SBC: MAKSCIENTIFIC            Topic: 400

    RESEARCH andampRELATEDUnitPROJECT SUMMARY ABSTRACT In response to PAthe aim of this Phase I STTR proposal is to optimize and develop peripherally actingcannabinoidreceptorCB Rneutral antagonists displaying favorable therapeutic profiles for treating diabetic nephropathyDNDN is a chronic diabetic kidney disease and affectstypeand typediabetic patientsIt is characterized by persistent albuminuria an ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government